The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
How Will The Market Value Of The Joint Pain Injections Market Increase Between 2026 And 2030?
The joint pain injections market has experienced substantial expansion in recent years. Its size is expected to increase from $6.12 billion in 2025 to $6.89 billion in 2026, achieving a compound annual growth rate (CAGR) of 12.5%. The historical growth of this market is attributable to the increasing prevalence of arthritis and joint disorders, an aging global population, the rising demand for minimally invasive pain treatments, growing awareness of regenerative therapies, and the expansion of orthopedic specialty care.
The joint pain injections market size is anticipated to experience substantial growth in the upcoming years. It is projected to expand to $10.96 billion by 2030, achieving a compound annual growth rate (CAGR) of 12.3%. The projected growth is largely driven by factors such as the increasing acceptance of biologic pain therapies, a rising emphasis on personalized medicine, the expansion of sports injury management practices, growing investments in regenerative medicine, and an increasing preference for non-opioid pain management solutions. Significant trends expected during this forecast period involve the rising adoption of non-surgical pain management therapies, the increasing use of hyaluronic acid and PRP injections, a growing demand for personalized pain treatment approaches, the broader availability of regenerative medicine-based injections, and an enhanced focus on outpatient pain relief solutions.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6482&type=smp
What Influential Factors Are Boosting The Joint Pain Injections Market Demand?
The increasing occurrence of arthritis and musculoskeletal disorders is anticipated to boost the expansion of the joint pain injections market. Musculoskeletal disorders stand as the leading cause of disability across the globe, with low back pain specifically being the most prevalent cause of impairment in 160 nations. Patients utilize injections for both pain relief and inflammatory conditions. For example, in August 2023, the Institute for Health Metrics and Evaluation (IHME), an independent U.S.-based health research organization, indicated that close to 1 billion people are expected to have osteoarthritis by 2050. Thus, the growing prevalence of arthritis and musculoskeletal disorders acts as a significant catalyst for the joint pain injections market.
What Are The Major Segment Categories Within The Joint Pain Injections Market?
The joint pain injections market covered in this report is segmented –
1) By Type Of Injection: Steroid Joint Injection, Hyaluronic Acid Injections
2) By Joint Type: Hip Joint, Knee And Ankle, Shoulder And Elbow, Facet Joints Of The Spine, Other Joint Types
3) By Distribution channel: Hospital Pharmacies, Retail Pharmacies
Subsegments:
1) By Steroid Joint Injection: Corticosteroid Injections, Combination Steroid Injections
2) By Hyaluronic Acid Injections: Single-Dose Hyaluronic Acid Injections, Multi-Dose Hyaluronic Acid Injections
What Trends Are Driving Changes In The Joint Pain Injections Market?
Major companies in the joint pain injection market are concentrating on creating innovations, such as single-injection formulations, which prioritize patient ease. A single-injection formulation is a drug delivery method designed to administer a specific medication dose in one shot, providing lasting therapeutic effects over an extended period without requiring multiple doses. For instance, in July 2024, LG Chem Ltd., a South Korea-based chemicals company, launched Synovian, a new knee osteoarthritis treatment in China featuring a convenient single-injection formulation, making it the first of its kind in the country. The product aims to enter a significant market valued at approximately KRW 200 billion (around USD 150 million). Developed with proprietary technology, it demonstrates innovation in meeting patient needs, focusing on delivering effective relief with minimal administration effort.
Who Are The Firms Contributing To The Joint Pain Injections Market Ecosystem?
Major companies operating in the joint pain injections market are Seikagaku Corporation, Anika Therapeutics Inc., Bioventus Inc., Flexion Therapeutics Inc., Ferring Pharmaceuticals Inc., Sanofi S.A., AbbVie Inc., Pfizer Inc., Teva Pharmaceutical Industries Limited, Merck & Co. Inc., Johnson & Johnson, Sun Pharmaceutical Industries Ltd., Zydus Lifesciences Limited, Wockhardt Ltd., Mallinckrodt Pharmaceuticals Ltd., Mylan N.V., Bayer AG, Eli Lilly and Company, Ipsen SA, Takeda Pharmaceutical Company Limited, AstraZeneca plc
Access The Complete Joint Pain Injections Market Report:
https://www.thebusinessresearchcompany.com/report/joint-pain-injections-global-market-report
Which Region Has The Strongest Presence In The Joint Pain Injections Market?
North America was the largest region in the joint pain injections market in 2025. The regions covered in the joint pain injections market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access a Joint Pain Injections Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/report/joint-pain-injections-global-market-report
Browse Through More Reports Similar to the Global Joint Pain Injections Market 2026, By The Business Research Company
Pain Management Drugs Market Report 2026
https://www.thebusinessresearchcompany.com/report/pain-management-drugs-global-market-report
Bone And Joint Health Supplements Market Report 2026
Non Opioid Pain Patch Market Report 2026
https://www.thebusinessresearchcompany.com/report/non-opioid-pain-patch-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model